Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Hikma Pharmaceuticals USA Inc. recalls Lorazepam Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds
Products
  • Lorazepam Injection
Where it was sold

Distributed Nationwide in the USA

Nationwide

Units affected
382,775 1mL vials
About this recall
Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25